期刊文献+

辛伐他汀对PTHrP诱导破骨细胞形成及小鼠颅盖骨代谢的影响

Effect of simvastatin on PTHrP stimulated osteoclastic resorption and anabolism of murine calvarium
下载PDF
导出
摘要 目的:探讨辛伐他汀对体外甲状旁腺素相关肽(PTHrP)诱导小鼠的破骨细胞骨吸收功能的作用及其小鼠骨代谢的影响。方法:采用PTHrP诱导小鼠骨髓细胞培养破骨细胞和小鼠颅盖骨培养体系,检测辛伐他汀作用8d后破细胞骨数目和培养上清钙的变化;检测小鼠颅盖骨培养上清碱性磷酸酶和钙含量,组织学观察小鼠颅盖骨形态学变化。结果:辛伐他汀体外可明显抑制PTHrP诱导小鼠的破骨细胞骨吸收陷窝的形成及培养上清钙的释放,辛伐他汀体外可增强小鼠颅盖骨培养上清碱性磷酸酶的活性,组织学观察到辛伐他汀使小鼠颅盖骨矿化增强。结论:辛伐他汀体外不仅可促进小鼠颅盖骨的成骨活性,并且可明显抑制PTHrP诱导小鼠的破骨细胞骨吸收功能,对骨吸收性疾病有着重要的防治作用。 Objective:To study the effect of simvastatin on PTHrP stimulated osteoclastic resorption of murine calvarium and bone anabolism in vitro. Methods:Osteoclasts were isolated from bone marrow of Balb/C mice, cultured and identified. Calvaria of the new born Balb/C mice were cultured with PTHrP at 45 ng/ml and/or simvastatin at 10^-7 - 10^-5 mol/L for 8 d. Ca^2+ and ALP in the culture supernatent were measured by atom spectrophotometer and automatic biochemical analyzer respectively. The bones were examined histologically. Results: Simvastatin at 10^-7 - 10^-5 mol/L inhibited osteoclast formation and the osteoclastic bone resorption stimulated by PTHrP in vitro and reduced the release of Ca^2+ from the cultured osteoclasts in a dose-dependent manner. Simvastatin increased the ALP activities and bone mineralization of murines calvaria cultured in vitro. Conclusions:Simvastatin may inhibit the osteoclasric resorption stimulated by PTHrP and promote bone mineralization in vitro.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2006年第3期378-382,共5页 Journal of Practical Stomatology
关键词 辛伐他汀 破骨细胞 骨吸收 甲状旁腺素相关肽(PTHrP) Simvastatin Osteoclast Bone resorption Parathyroid hormone related peptide
  • 相关文献

参考文献10

  • 1Mundy GR,Garrett R,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins.Science,1999,286(5446):1946.
  • 2Vander Horst G,Van Bezooijen RL,Deckers MM,et al.Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation.Bone,2002,31(6):661.
  • 3Wang EA,Israel DI,Kelly S,et al.Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells.Growth FacEors,1993,9(1):57.
  • 4Martin TJ.Humoral hypercalcemia of maliganacy.Bone Miner,1988,4(1):83.
  • 5Mundy GR.Hypercalcemia of maliganacy revisited.J Clin Invest,1988,82(1):1.
  • 6陶惠人,王全平,李寰.甲状旁腺素相关肽诱导骨髓细胞生成破骨细胞及对骨吸收的影响[J].中国临床康复,2004,8(17):3250-3251. 被引量:6
  • 7许多荣,余学清,方荸荠.甲状旁腺激素在体外对破骨细胞分化及骨重吸收能力的影响[J].中华肾脏病杂志,2005,21(4):186-190. 被引量:14
  • 8Coxon FP,Helfrich MH,Van't Hof R,et al.Protein geranylgeranylation is required for osteoclast formation,function and survival:Inhibition by bisphosphonates and GGTI-298.J Bone Miner Res,2000,15(8):1467.
  • 9Grasser WA,Baumann AP,Petras SF,et al.Regulation of osteoclast differentiation by statins.J Musculoskelet Neuronal Interact,2003,3(1):53.
  • 10Von Knoch F,Wedmeyer C,Heckelei A,et al.A comparison of the antiresorption effects of bisphosphonates and statins on polyethylene particle-induced osteilysis.Biomed Tech (Berl),2005,50(6):195.

二级参考文献24

  • 1Fong AM, Erickson HP, Zachariah JP, et al. Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation. J Biol Chem, 2000,75: 3781-3786.
  • 2Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the members of the tumor necrosis factor receptor and ligand fanilies. Endocr Res, 1999,20: 345-357.
  • 3Duorong Xu,Zhenqi Shi,Xu Feng,et al. Development of a chimacric receptor approach to study signaling by tumour necrosis factor family members. Biochem J, 2004,383:219-225.
  • 4Wei L, Duorong X, Hongmei Y, et al. Functional identification of three RANK cytoplasmic motif mediating osteoclast differentiation and function. J Biol Chem, 2004,279:54759-54769.
  • 5Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteogenesisinhibitory factor and is identical to TRANCE/RANKL.Proc Natl Acad Sci UAS, 1998,95:3597-3602.
  • 6Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the members of the tumor necrosis factor receptor and ligand families. Endocr Res, 1999,20: 345-357.
  • 7Hofbauer L, Khosla S, Dunstan C, et al. The roles of osteoprotegerin and osteoprogerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res,2000, 15:2-12.
  • 8Shi W, Michael WH, Steven L, et al. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and Mitogen-activated protein kinase signaling. J Biol Chem,2002,277: 6622-6630.
  • 9Simonet W, Lacey D, Dunstan C, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 1997,89: 309-319.
  • 10Schiller P, Ippolito G, Roos B, et al. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment.J Bone Miner Res, 1999,14: 1504-1512.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部